Ethical Profile
Mixed.
Not enough information to create an ethical profile.
INmune Bio Inc..
INMB.US | Research and experimental development on natural sciences and engineering
INmune Bio, Inc. is a clinical-stage biotechnology company focused on developing therapies that harness the innate immune system to fight disease. The company's primary focus is on developing treatments for neurodegenerative diseases, such as Alzheimer's disease and Multiple Sclerosis, by targeting ...Show More
Similar Companies
Value Scores
Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals-30
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100
Better Health for All
0
No evidence available to assess INmune Bio Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
INmune Bio Inc. is a clinical-stage biotechnology company focused on developing therapies, not financial services. The provided articles do not contain any information or specific data points related to financial products, lending, or economic opportunity initiatives for consumers.
1
Therefore, all KPIs under the 'Fair Money & Economic Opportunity' value are not applicable to the company's business model, and no evidence was found to score them.Fair Pay & Worker Respect
0
The provided articles do not contain specific, concrete data points for any of the KPIs under the 'Fair Pay & Worker Respect' value. Information regarding living wage coverage, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, insecure contract share, and health insurance coverage is not available.
1
While CEO compensation figures are provided, the crucial median employee compensation data required to calculate the CEO-to-median employee pay ratio is explicitly stated as missing, making it impossible to score this KPI. 2
Furthermore, there is no specific count of substantiated labor-law or human-rights violations. 3
Fair Trade & Ethical Sourcing
0
No specific, concrete data points related to fair trade or ethical sourcing practices for INmune Bio Inc. were found in the provided articles. The articles primarily discuss general biopharmaceutical industry news, FDA actions, drug approvals, and INmune Bio's clinical development approach, without addressing supply chain management, supplier audits, ethical clauses, or material sourcing details.
Honest & Fair Business
0
No evidence available to assess INmune Bio Inc. on Honest & Fair Business.
Kind to Animals
-30
INmune Bio Inc. is a clinical-stage biotechnology company, and its operations are not applicable to several animal welfare KPIs, such as cruelty-free certifications, humane certifications for animal operations, ethical input substitution, supplier audits, or cage-free sourcing. The company's Code of Ethics does not explicitly mention an animal testing policy, indicating a vague or absent policy.
1
The company uses animal testing for compounds like pSar DN-TNF and INB03™, and also mentions pre-clinical models, while conducting in-vitro studies for INKmune™. 2
The company reported using 25,000-50,000 animals annually in its testing. Research and development expenses totaled approximately $17.1 million for the year ended December 31, 2022, 3
and $4.1 million for the quarter ended June 30, 2023, 4
but there is no explicit evidence of investment in animal-free technologies.No War, No Weapons
0
No evidence available to assess INmune Bio Inc. on No War, No Weapons.
Planet-Friendly Business
0
No evidence available to assess INmune Bio Inc. on Planet-Friendly Business.
Respect for Cultures & Communities
0
No evidence available to assess INmune Bio Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No specific evidence was found in the provided articles regarding INmune Bio Inc.'s performance across any of the Safe & Smart Tech KPIs. The articles either discuss general industry trends and breaches or explicitly state that no data is available for INmune Bio Inc. on these topics. While one article mentions INmune Bio Inc.'s compliance with SEC regulations for a direct offering, this pertains to financial regulatory compliance and not the privacy-specific regulatory compliance evaluated by this value.
1
Zero Waste & Sustainable Products
0
No specific, concrete evidence was found in the provided articles for any of the KPIs related to Zero Waste & Sustainable Products. While the company mentions leveraging economies of scale and other resources to strategically manufacture products with resource and environmental efficiencies, this statement is too general and does not provide quantifiable data or specific actions for waste diversion, product recyclability, packaging sustainability, or any other detailed waste-related metric required by the rubric.
1
Own INmune Bio Inc.?
Upload your portfolio and see how all your holdings score across 11 ethical dimensions.
Audit My PortfolioAI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.